KOLON CORPORATION Logo

KOLON CORPORATION

A holding company for diverse businesses in materials, chemicals, fashion, and life sciences.

002020 | KO

Overview

Corporate Details

ISIN(s):
KR7002020006
LEI:
Country:
South Korea
Address:
경기 과천시 별양동 1-23 코오롱타워, 과천시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Kolon Corporation is the holding company for the KOLON Group, a South Korean conglomerate with a diverse portfolio of businesses. The corporation focuses on improving management efficiency and streamlining decision-making processes for its core subsidiaries. The group's primary business divisions operate in sectors including industrial materials, chemicals, film/electronic materials, fashion, and life sciences. Kolon Corporation drives the group's overall strategy, emphasizing continuous innovation, sustainability, and ESG (Environmental, Social, and Governance) values through a model of autonomous management for its affiliated companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Registration Form
증권신고서(주식의포괄적교환ㆍ이전)
Korean 10.0 MB
2025-09-10 00:00
M&A Activity
[기재정정]주요사항보고서(주식교환ㆍ이전결정)(자회사의 주요경영사항)
Korean 64.9 KB
2025-09-10 00:00
M&A Activity
[기재정정]주요사항보고서(주식교환ㆍ이전결정)
Korean 58.2 KB
2025-09-01 00:00
Major Shareholding Notification
[기재정정]대규모기업집단현황공시[분기별공시(대표회사용)]
Korean 51.6 KB
2025-08-29 00:00
Regulatory News Service
단일판매ㆍ공급계약체결(자회사의 주요경영사항)
Korean 8.8 KB
2025-08-27 00:00
Major Shareholding Notification
대규모기업집단현황공시[분기별공시(대표회사용)]
Korean 48.5 KB
2025-08-27 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결(자회사의 주요경영사항)
Korean 15.5 KB
2025-08-26 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 19.2 KB
2025-08-26 00:00
Capital/Financing Update
타인에대한채무보증결정(자회사의 주요경영사항)
Korean 19.6 KB
2025-08-25 00:00
Legal Proceedings Report
소송등의제기ㆍ신청(일정금액이상의청구)(자회사의 주요경영사항)
Korean 9.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 9.3 MB
2025-08-08 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 2.1 KB
2025-08-07 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정(자회사의 주요경영사항)
Korean 7.1 KB
2025-08-07 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 9.9 KB
2025-08-07 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정(자회사의 주요경영사항)
Korean 15.1 KB

Automate Your Workflow. Get a real-time feed of all KOLON CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOLON CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOLON CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.